Search academic texts

Information × Registration Number 0305U005231, 0105U002092 , R & D reports Title A Randomizet, Double Blind, Active-Controlled Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects with Non-Myeloid Malignancy Receiving Multicycle Chemotherapy. popup.stage_title Досліджено ефективність та систематизація інформації щодо ефективності Дарбепоетіну Альфа при лікуванні анемії та її обробка (статистика). Head Hotko Evgen S., Registration Date 08-08-2005 Organization Uzhgorod National University popup.description2 Preparation Darbepoetin alpha has shown significant activity at his application for patients with malignant tumorrs which have an anemia induced by chemotherapy. At application both weekly injections, and the depot - form, the insignificant quantity of the side-effecrs which are not demanding corrections of dozes of a preparation was observed. At application Darbepoetin alpha it is necessary to use monitoring behind parameters of red blood for the prevention of a thromboembolic complications.5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close